Augmenix Announces Positive Five-Year Long-Term Data Highlighting Significant Bowel and Sexual Quality of Life Benefits for Prostate Cancer Patients Treated with SpaceOAR® Hydrogel

PRESS RELEASE: Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during prostate radiotherapy (RT), announced that the International Journal...